Introduction {#Sec1}
============

Oncolytic virotherapy is a novel cancer treatment where natural or genetically modified viruses infect cancer cells and then self-replicate until the host cancer cells lysis (see Fig. [1](#Fig1){ref-type="fig"}). Ruptured cancer cells release chemicals like tumor antigens, which make cancer cells easily recognizable by the immune system. Moreover, the released viruses can infect more cancer cells to trigger a chain reaction and effectively act as a follow-up treatment. As early as in 1912, De Pace ([@CR10]) observed a tumor regression after inoculation of an attenuated rabies vaccine in a patient with uterine cervical carcinoma. Later on, an animal-based test (Levaditi and Nicolau [@CR29]) and a human trial (Pack [@CR35]) were conducted in 1920 and 1940, respectively, where both experiments yielded an obvious partial tumor regression (Kasuya et al. [@CR23]). In the subsequent decades, more works (Kirn [@CR25]; Gil et al. [@CR17], [@CR18]) demonstrated that oncolytic virotherapy lead to tumor attenuation. Some milestones in the development of oncolytic virotherapy are shown in Fig. [2](#Fig2){ref-type="fig"} (De Pace [@CR10]; Martuza et al. [@CR31]; Xia et al. [@CR48]; Fukuhara et al. [@CR16]).Fig. 1A schematical figure of oncolytic virotherapy. The viruses can specifically infect cancer cells and then replicate themselves until cancer cells rupture. Subsequently, the newborn viruses are released to infect more cancer cellsFig. 2Historical milestones in the development of oncolytic virotherapy

Pancreatic ductal adenocarcinoma (PDA), recognized as the most common pancreatic cancer, is a lethal disease due to late detection, a low resectability rate, medication resistance and poor prognosis (Korc [@CR26]; Gore and Korc [@CR19]). Currently, pancreatic cancer is the seventh leading cause of cancer death worldwide and its 5-year survival rate is less than 5% (Feig et al. [@CR14]; Bray et al. [@CR4]). Compared with other types of cancer, PDA has more cancer-associated fibroblasts (CAFs) resulting in abundantly desmoplasitic stroma that constitutes up to 90% of a solid tumor volume (Moir et al. [@CR32]; Öhlund et al. [@CR34]). The profuse desmoplasia in stroma produced by CAFs acts as a physical barrier for drug delivery and leads to medication resistance (Provenzano et al. [@CR38]; Jacobetz et al. [@CR22]). However, CAFs make cancer cells more susceptible to be infected by oncolytic viruses. Ilkow et al. ([@CR21]) experimentally demonstrated that the cross-talk between cancer cells and CAFs facilitates the oncolytic virus-based therapies. Therefore, oncolytic virotherapy offers an avenue for the treatment of pancreatic cancer.

The ideal oncolytic virus should be able to selectively replicate itself in cancer cells without damaging normal somatic cells (see Fig. [1](#Fig1){ref-type="fig"}). A couple of studies (Sunamura et al. [@CR42]; Kasuya et al. [@CR23]; Wennier et al. [@CR45]) summarized advantages and disadvantages of various replication-competent oncolytic viruses proposed for pancreatic cancer therapies, e.g., adenoviruses, herpesviruses, poxviruses, parvoviruses, reoviruses and paramyxoviruses. A few types of viruses have been tested in animal-based xenograft models; however, only a few kinds of viruses have reached clinical trials. In particular for pancreatic cancer, relevant studies are rare, among which Fu et al. ([@CR15]) observed that a type of oncolytic virus produced antitumor effects in human pancreatic cancer xenografts. In addition, Sunamura et al. ([@CR42]) carried out adenovirus therapy in immunodeficient mice with human pancreatic cancer xenografts that resulted in a remarkable inhibition of tumor growth under consecutive injections of the virus. Typically, if animal testing is successful, the new drug will reach clinical trials that are classified into four phases: (1) phase I is a safety test for healthy volunteers; (2) phase II demonstrates whether a drug can have any efficacy against the disease; (3) phase III checks in a randomized multicenter tests if a drug has the right therapeutic effect; and (4) phase IV post-marketing surveillances its efficacy and side effects after extensive use. Regarding the clinical applicability, Kasuya et al. ([@CR23]) stated that a clinical trial of viruses adenovirus ONYX-015 (phase I and II) has been conducted in pancreatic cancer patients, where half of the patients (phase II) exhibited either tumor reduction or stabilization. In contrast, a phase I trial of the efficacy of several oncolytic herpes viruses (such as G207, 1716 and OncoVEX GM-CSF) have tested against various tumors and the herpesvirus exhibited a good tolerance at all dosages. Although oncolytic virotherapy has been proposed for decades, a thorough understanding of the interactions of virus, tumor and microenvironment in vivo is still needed to be further researched, like a proper viral dose for a specific virus, how to control of virulence and etc. Therefore we develop a three-dimensional (3D) spatial Markov Chain cellular automata model to mimic pancreatic tumor (pancreatic cancer at early stages) progression and subsequent regression under the interference of oncolytic virotherapy. In addition, the model can be used to quantify the impact of virotherapy with different viral doses, viral infectivity and levels of immunity in patients with pancreatic cancer.

Cellular automata models are lattice-based models that facilitate analysis of the spatiotemporal dynamics based on the interplay between cells and their microenvironment. The cellular automata model has been introduced as a computer model of self-reproduction by John von Neumann and Stanislaw Ulam (Langton [@CR28]). In the past decades, cellular automata models, in addition to self-reproduction, have been extended to other model applications successfully within a wide range of spectrum from biology, physics, chemistry to other sciences (Deutsch et al. [@CR11]). Regarding the cancer modeling in cellular automata, Reis et al. ([@CR40]) proposed a model that could capture the Gompertzian behavior of tumor growth. Hatzikirou et al. ([@CR20]) developed a model of tumor invasion dynamics. In addition, a couple of studies demonstrated applications of cellular automata in cancer therapy, e.g., radiotherapy (Enderling et al. [@CR13]), and chemotherapy (Pourhasanzade and Sabzpoushan [@CR37]). In terms of computational models on oncolytic virotherapy, Wodarz et al. ([@CR46]) studied the distinct patterns of oncolytic viral spreading through tumor cell population both experimentally and computationally. Furthermore, Paiva et al. ([@CR36]) developed a multiscale cellular automata model for oncolytic virotherapy, where authors found that a solid tumor can be either eradicated completely or keeps on growing. The resulting behavior depends on the input parameters, which represent the biological circumstances around the tumor. Malinzi et al. ([@CR30]) developed a partial differential equation-based model for oncolytic virotherapy. For the one-dimensional case, they assessed the stability of traveling wave solutions and the rate of tumor progression by means of the minimal traveling wave speed. One of their most important conclusions is that the combination of chemotherapy and virotherapy most successfully removes tumors.

The 2D model in Paiva et al. ([@CR36]) revealed an oscillatory behavior of cancer cells and virus population, which hints a strong host immune response is necessary. As an extension of this model, we develop a 3D model to phenomenologically show pancreatic cancer initiation at early stages and its subsequent regression under oncolytic virotherapy, where the various levels of host immune responses and toxicities of residual viruses are taken into account. To the best of our knowledge, it is the first description of a hybrid cellular automata model with an application to pancreatic cancer. In addition, this model also shows the pattern of virus spreading by using partial differential equations in a spatial domain. One of the advantages is its efficacy in evaluation of therapeutic outcomes based on injected dose of viruses, viral infection potent and personal immune strength. Next to the development of the model, we calibrate the model to experimental outcomes and we carry out an uncertainty quantification by using Monte Carlo simulations in terms of assessment of the likelihood of success of the treatments. Therefore, therapeutic effects as well as toxicities of residual viruses are predicted, which is expected to be helpful for viral administration and the patient-specific treatment.

Mathematical Formalism {#Sec2}
======================

Cellular automata models consist of a class of lattice-based models, where lattice approaches are classified as: (1) a single lattice site is occupied by one cell only; (2) a single lattice site is occupied by a cluster of cells; (3) one cell takes many lattice sites. They are all capable of investigating biological processes with single cell or multiple cells, where division, death or other biomedical phenomena are modeled by stochastic processes (Van Liedekerke et al. [@CR43]). In contrast, the first two categories are typically used to describe volume effects, whereas the last category is able to capture the morphological evolution of cells.
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Subsequently, we consider fundamental biological processes like cell division, mutation, infection and death modeled as stochastic processes. The likelihood of changing a state of a lattice *i* to another state satisfies a memoryless exponential distribution which is given by $\documentclass[12pt]{minimal}
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Oncolytic virotherapy is initiated when the fraction of tumor constitutes up to 100% of the computational domain (that is the tissue). In animal-based experiments, the viruses are given by injections (Sunamura et al. [@CR42]). Therefore, we consider one or multiple injections, denoted by $\documentclass[12pt]{minimal}
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                \begin{document}$$u(\mathbf{x})$$\end{document}$ is utilized to model an increase in production of viruses released by necrotic cancer cells. Moreover, *T* represents the mass transfer rate coefficient between the computational domain $\documentclass[12pt]{minimal}
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                \begin{document}$$N_v$$\end{document}$ denote the proliferation rate of virus and a burst size of viruses from a necrotic cancer cell. The function $\documentclass[12pt]{minimal}
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                \begin{document}$$u(\mathbf{x})$$\end{document}$ is a hypothetic function that accounts for the regeneration of virus particles as long as the cancer cell has been infected. We assume that the carrying capacity of the viral particles is determined by the availability of limited amounts of resources in the cancer cell. This assumption translates into the above logistic differential equation. This function can be revised easily if experimental observations require this.
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Numerical Method {#Sec3}
================

Discretization {#Sec4}
--------------

We first consider a 2D or 3D that is occupied by uninfected cancer cells, where a dose of oncolytic viruses is injected into the computational domain as part of the therapy. Subsequently, viruses diffuse and thereby spread throughout the domain. The change in concentration of viruses is modeled by the reaction diffusion equation$$\documentclass[12pt]{minimal}
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                \begin{document}$$\begin{aligned} {\left\{ \begin{array}{ll} \frac{\partial c}{\partial t} = D {\Delta } c + \gamma \delta (\mathbf{x} - \mathbf{x}_p) + \beta c (1-\frac{c}{N_v}),&{}\quad { \ \text {for} \ \mathbf{x} \in \ {\Omega }}\\ D\frac{\partial c}{\partial n} + T c = 0, &{}\quad \mathrm {on} \ \partial {\Gamma } \end{array}\right. }. \end{aligned}$$\end{document}$$Note that the above equation is a combination of Eqs. ([9](#Equ9){ref-type=""}) and ([10](#Equ10){ref-type=""}), in which we only take one injection source into account. The numerical method is described for the case of only one injection source since our simulations are only carried out for one source only. We note that incorporating multiple injection sources would not change the numerical method conceptually.

To solve the problem in 2D, the Laplace operator is discretized by the finite difference method (FDM) as,$$\documentclass[12pt]{minimal}
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                \begin{document}$$\begin{aligned} c(-h, y, z, t) = c(h, y, z, t)- c(0, y, z, t)\left( 1-\frac{2T}{D}h\right) . \end{aligned}$$\end{document}$$Analogously, the viral concentration on the other virtural points can be obtained by$$\documentclass[12pt]{minimal}
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                \begin{document}$$\varepsilon $$\end{document}$ and *d*, respectively, denote the source width and the dimensionality.

Time Integration {#Sec5}
----------------

To update the concentration of virus on each lattice at the next time step, an IMplicit-EXplicit(IMEX) time integration is utilized, where the linear parts and nonlinear parts are treated by a Euler backward method and a Euler forward method, respectively. Thereby the concentration of virus *c* is updated by$$\documentclass[12pt]{minimal}
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                \begin{document}$$\begin{aligned} c^{n+1} = c^n + {\Delta } t\left( D {\Delta } c^{n+1} +{\gamma }\delta \left( \mathbf{x} - \mathbf{x}_p\right) + \beta c^n \left( 1-\frac{c^{n+1}}{N_v}\right) \right) . \end{aligned}$$\end{document}$$Note that this IMEX approach avoids the need of inner iterations to solve a nonlinear problem at each time step. We have used the finite difference scheme on several mesh sizes and time steps and we find that enlarging the resolution dose not yield any significant changes in the approximation for the current numerical setting (see Table [2](#Tab2){ref-type="table"}).

Monte Carlo Simulation {#Sec6}
----------------------

Monte Carlo simulations are widely used in many quantitative probabilistic and statistical investigations that permeates much of finance, engineering and contemporary sciences (Kroese et al. [@CR27]). To obtain quantities of interest, such as (cumulative) probability distributions of output variables and correlations, Monte Carlo simulations enable random sampling of input parameters from predefined probability distributions and extensive repetitive experiments.

Due to the variety of viruses and variations from patient to patient, many variables can hardly be determined or measured. For instance, the dose of a virus $\documentclass[12pt]{minimal}
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                \begin{document}$$\beta $$\end{document}$, may all depend on patient lifestyle, gender and genetic pattern, and hence vary from patient to patient. However, the above-mentioned variables may be quantitatively correlated to viral treatment outcomes, and thereby Monte Carlo simulations are performed on $\documentclass[12pt]{minimal}
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                \begin{document}$$X\in \{\gamma ,\hat{c},\alpha , \beta \}$$\end{document}$. We assume that *X* follows a normal distribution $\documentclass[12pt]{minimal}
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                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$N_s$$\end{document}$, therefore 5000 samples are chosen to guarantee a small error.

Numerical Results {#Sec7}
=================

To perform the simulations, the most numerical parameters have been listed in Table [2](#Tab2){ref-type="table"}.Table 2Numerical parametersParametersNotationValue and UnitsComputational domain$\documentclass[12pt]{minimal}
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Fig. 4Consecutive snapshots of cancer progression, where blue color and red color are visualized as epithelial and cancer cells, respectively. The 3D domain $\documentclass[12pt]{minimal}
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Cancer Progression {#Sec8}
------------------

We consider a cubic domain to represent the tissue in the pancreas. The 3D domain $\documentclass[12pt]{minimal}
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                \begin{document}$$N_c(t)$$\end{document}$ denotes the number of lattice points in cancer state $\documentclass[12pt]{minimal}
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                \begin{document}$$\{S_i = 2\}$$\end{document}$ at time *t*. To model cancer mutation occurring at the edge of a tissue or organ and its competitive growth with epithelial cells, a small number of lattice points are generated randomly in one octant of the domain only (see Fig. [4](#Fig4){ref-type="fig"}a). Those lattice points are initiated with epithelial cell state indicated by blue color. Due to mutation, several lattice points change their states from $\documentclass[12pt]{minimal}
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                \begin{document}$$\{S_i = 2\}$$\end{document}$ that are visualized by the red dots (see Fig. [4](#Fig4){ref-type="fig"}a). Typically, normal cells stop dividing once they contact with each other during division as a result of contact inhibition, which can prevent excessive proliferation. Contrarily, mutated cancer cells often show uninterrupted growth that is called 'autonomous growth'. Moreover, cancer cells disperse more easily and invade the neighborhood tissue. Therefore, they have a larger growth and division rate despite limited space and nutrient supply. In the current simulation, the probability of mutation, proliferation and death is based on Eq. ([3](#Equ3){ref-type=""}) and several consecutive snapshots are shown in Fig. [4](#Fig4){ref-type="fig"}.

After 1400 hours (approximate 58 days), cancer cells occupy the entire computational domain and its corresponding growth curve with the respect of time indicated in red color is shown in Fig. [5](#Fig5){ref-type="fig"}a. According to Eq. ([8](#Equ8){ref-type=""}), the growth of cancer cells is influenced by $\documentclass[12pt]{minimal}
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As an example, Fig. [5](#Fig5){ref-type="fig"}b shows experimental results of tumor growth curve from the work by Durrant et al. ([@CR12]), where pancreatic cancer cells are inoculated into immunodeficient mice, where the inoculation site is subcutaneous. Implanted cancer cells are allowed to grow during two weeks before the initiation of gemcitabine drug treatment ($\documentclass[12pt]{minimal}
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                \begin{document}$${100}\,{\upmu \mathrm{g}/\mathrm{kg}}$$\end{document}$) and its growth curve is indicated by the blue curve in Fig. [5](#Fig5){ref-type="fig"}b. As a control experiment, the black curve in Fig. [5](#Fig5){ref-type="fig"}b exhibits the growth of inoculated tumor without treatment. To mimic the tumor progression in this situation, we set up a model with a number of cancer cells initially in the domain. With minor variations of $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$\lambda _i$$\end{document}$ in Eq. ([4](#Equ4){ref-type=""}), our model is able to simulate various growth modes of pancreatic tumor (indicated by the red lines in Fig. [5](#Fig5){ref-type="fig"}b), which fits the experimental results well. Over 50 days, our numerical results regarding the increase in tumor volume show a consistency with the experimental work (Durrant et al. [@CR12]).

Oncolytic Virotherapy {#Sec9}
---------------------

Oncolytic virotherapy has been recognized as a promising cancer treatment approach. We first develop a phenomenological model of oncolytic virotherapy in 3D, where the intratumoral injection of the virus is taken into consideration. The spread of viruses is simulated by the reaction-diffusion equation that is solved by using the FDM method. As a result, the diffusion of viruses in two different situations at time $\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {mm}^3$$\end{document}$ in Fig. [6](#Fig6){ref-type="fig"}a. This is mainly due to a slow viral diffusivity (Bajaj et al. [@CR2]) and insufficient viruses supply. The isosurface in Fig. [6](#Fig6){ref-type="fig"}b indicates that a small amount of viruses has spread near the boundary. Note that irregular isosurface in grey color has a concentration value of slightly less than 100 pfu $\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {mm}^3$$\end{document}$.Fig. 6A comparison of viruses diffusion by using the FDM method with a color bar indicating the concentration of viruses, where red color represents a high concentration of virus, dark blue hints a neglectable viral concentration and other colors denote values in between. **a** No cancer cells are present and viral infection is not simulated, which means no new proliferating viruses. Therefore, most viruses are mainly concentrated in the center; **b** In the presence of cancer cells, viral infection ensues, viruses replicate leading to rupture of cancer cells, which then releases the viruses. The viruses are thus found also at distant locations. The isosurface in grey color has a concentration value of slightly less than 100 pfu $\documentclass[12pt]{minimal}
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                \begin{document}$$\hbox {mm}^3$$\end{document}$Fig. 7Consecutive slice plots of viral spread. No cancer cells are present and viral infection is not simulated, which means no new proliferating viruses. The slices are taken from the angle of a z-axis top view, which is located in the middle of the computational domain. A color bar indicates the concentration of viruses

In addition, viral diffusion with the time evolution (when $\documentclass[12pt]{minimal}
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                \begin{document}$$t = 1, 10, 50, 100 \ \mathrm {h}$$\end{document}$) of each situation is shown by slices in Figs. [7](#Fig7){ref-type="fig"} and [8](#Fig8){ref-type="fig"}, respectively. The slices are taken from the angle of a z-axis top view, which is located in the middle of the computational domain. Figure [7](#Fig7){ref-type="fig"} presents a slow and relatively smooth diffusion phenomenon, with no viruses on the computational boundary at $\documentclass[12pt]{minimal}
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                \begin{document}$$t = 100 \ \mathrm {h}$$\end{document}$. However, viral spread in Fig. [8](#Fig8){ref-type="fig"} is faster as a result of the supply new breeding viruses from necrotic cancer cells and seems to be more random, which we think to be more in line with the infection and spread of viruses in reality. Eventually, some viruses spread to the edge and are dissipated from the border of the domain. Dissipated or remaining viruses after treatment might be removed by immune cells or, in worse cases, be virulent to healthy tissue. Therefore, it is vital to assess the toxicity of the remaining viruses after treatment.Fig. 8Consecutive slice plots of viral spread. In the presence of cancer cells (cancer cells are not shown for clarity), viral infection ensues, viruses replicate leading to rupture of cancer cells, which then releases the viruses. The slices are taken from the angle of a z-axis top view, which is located in the middle of the computational domain. A color bar indicates the concentration of viruses

To visualize the modeling progression of oncolytic virotherapy, some consecutive snapshots are shown in Fig. [9](#Fig9){ref-type="fig"}. An extension of the model in Fig. [4](#Fig4){ref-type="fig"}, where the computational domain $\documentclass[12pt]{minimal}
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                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
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                \begin{document}$$t = 0 \ \mathrm {h}$$\end{document}$, see Fig. [9](#Fig9){ref-type="fig"}a. Typically, viruses are injected intratumorally if cancer occurs under the epidermis (Rehman et al. [@CR39]), otherwise, intravenous injection is the main approach for virotherapy (Aghi and Martuza [@CR1]). However, the intravenous injections could cause many viruses to infect other tissue outside of the tumor, or be removed by the immune system or be dissipated before reaching the cancer area. To make the problem tractable, we consider one dose of intratumoral injection, which is given at the center of the domain. Subsequently, internal cancer cells will start to get infected, indicated in black color, and subsequently die, which is indicated by the white color, see Figs. [9](#Fig9){ref-type="fig"}b, c. Local cells at lattice point *i* may get infected once the local concentration of viruses exceeds the threshold, which is $\documentclass[12pt]{minimal}
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                \begin{document}$$\hat{c} = 10\,\hbox {pfu} \,\hbox {mm}^3$$\end{document}$. Afterward, infected cancer cells (black color in Fig. [9](#Fig9){ref-type="fig"}) are able to die (unoccupied grid nodes in white color) and release new breeding viruses with a burst size $\documentclass[12pt]{minimal}
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                \begin{document}$$S = 0$$\end{document}$ are reminiscent to a wound. Then a chain reaction is triggered such that the virotherapy speeds up. Since internal lattice points are released after the death of infected cancer cells, we suppose that the normal constitutive cells around the cancer region will migrate to this area and fill the wound by proliferation, see Fig. [9](#Fig9){ref-type="fig"}d--f.Fig. 9Consecutive snapshots of oncolytic virotherapy. The blue, red and black colors are visualized as epithelial, cancer and infected cancer cells, respectively. In addition, white color means the dead cells or unoccupied lattice points. A small scale of cancerous tissue that returns to normal tissue by cell reproduction or migration under the oncolytic virotherapy after $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$t = 110$$\end{document}$ h

The model describes an ideal virus type with a small dose to kill cancer cells, however, the role of the viral dose remains unclear. Since some viruses, like NDV, lead to a significant therapeutic benefit at high doses, whereas other viruses do not (Aghi and Martuza [@CR1]). However, different types of viruses have different side effects (Yu and Fang [@CR49]). The risk could be tiny symptoms, such as flu or fever (Cripe et al. [@CR9]), and also could be severe like fatal muscle toxicity or neurotoxicity (Russell et al. [@CR41]). Therefore, the evaluation of residual viruses after treatment is crucially important. In our model, according to the boundary condition in Eq. ([9](#Equ9){ref-type=""}), viruses will dissipate from the boundary to other tissues or organs. Thereby we estimate the remaining viruses in the modeled area and ignore the dissipated viruses when $\documentclass[12pt]{minimal}
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                \begin{document}$$t = 100$$\end{document}$ h. Figure [10](#Fig10){ref-type="fig"}a, b show changes in total viruses and cancer volume over time in the domain, respectively. At the beginning, a total dose $\documentclass[12pt]{minimal}
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                \begin{document}$$0.5\times 10^{4}$$\end{document}$ pfu/h) is given (see the enlarged view in Fig. [10](#Fig10){ref-type="fig"}a), where the domain is fully occupied by uninfected cancer cells with a volume as large as 3375 $\documentclass[12pt]{minimal}
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                \begin{document}$${\mathrm{mm}^3}$$\end{document}$ (see Fig. [10](#Fig10){ref-type="fig"}b). Once cancer cells get infected by viruses, successful viruses begin to replicate themselves until the host cancer cells rupture, which results in a significant increase in viral quantity and decrease in cancer volume. When time approaches 80 h, the number of viruses in the domain have accumulated to a peak (see Fig. [10](#Fig10){ref-type="fig"}a), whereas most cancer cells are damaged (see Fig. [10](#Fig10){ref-type="fig"}b). Furthermore, Fig. [10](#Fig10){ref-type="fig"}a shows that the number of viruses gradually decreases after 80 h and this is mainly because a fraction of viruses escapes from the domain boundary. Note that there is a minor decline in the number of viruses (see the enlarged view in Fig. [10](#Fig10){ref-type="fig"}a), which may be due to the fact that the actual number of viruses present exceeds the carrying capacity of viruses. In order to investigate whether there is a maximum capacity of viruses in a limited domain, various injection rates (i.e., $\documentclass[12pt]{minimal}
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                \begin{document}$$1\times 10^{5}$$\end{document}$ pfu/h) are compared. The results given in Fig. [11](#Fig11){ref-type="fig"} show that a larger viral dose leads to a greater decline in total particles after injection and do not affect the eventual result because of the maximum capacity of viruses in the computational domain. The results suggest that if a certain threshold is exceeded for the amount of injected viruses, then its temporal evolution is more or less the same.Fig. 10**a** Changes in viral quantity in the computational domain; **b** Changes in cancer volume with timeFig. 11**a** Changes in viral quantity as the evolution of time with an injection rate $\documentclass[12pt]{minimal}
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Monte Carlo Simulations {#Sec10}
-----------------------

Kelly and Russell ([@CR24]) showed that immunosuppressed patients normally have a better therapeutic benefit than those who have an intact immune system in oncolytic virotherapy. However, a defective immune system would lead to a large number of viruses, which is associated with unacceptable toxicity in most cases (Russell et al. [@CR41]). To make our model applicable to a wide range of virus species, the antiviral immune response is incorporated in the Monte Carlo simulations as one of the input variables, which we sample from a probability distribution. Therefore, Eq. ([9](#Equ9){ref-type=""}) is revised slightly to$$\documentclass[12pt]{minimal}
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In contrast, the infection threshold, which is used to represent the ability of viral infectivity, shows a significant correlation with the remaining viral quantity and cancer area in Fig. [14](#Fig14){ref-type="fig"}. The higher the threshold value, the higher the concentration of the virus is needed to infect the cancer cells, which hints at a lower ability of the viral infectivity. From Fig. [14](#Fig14){ref-type="fig"}a, the number of residual viruses decreases with increasing infection threshold since viruses with low infection ability are not able to damage cancer cells, but they can be eliminated by the antiviral immune response. Therefore, antiviral immune and insufficient newborn viruses facilitate cases with few residual viruses after 50 h. Certainly, the cancer area will not reduce significantly if the viral infection ability is weak. Viruses with a good infectivity ($\documentclass[12pt]{minimal}
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                \begin{document}$$\eta $$\end{document}$ denotes a strong antiviral immune response that would result in the death of most viruses. According to Fig. [15](#Fig15){ref-type="fig"}a, in the case of immunodeficiency, the residual viruses could accumulate to a large amount, while the amount falls as the immunity increases. When the antiviral response is strong like $\documentclass[12pt]{minimal}
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                \begin{document}$$\eta > 0.04$$\end{document}$. This indicates that patients with a weaker immune response may benefit from a larger reduction of the tumor size. However, at the same time, patients with a weak immune system are sensitive to have large amounts of residual viruses in their bodies.

Conclusions {#Sec11}
===========

Many animal-based experiments and clinical trials yielded a noticeable tumor attenuation by using oncolytic viruses (De Pace [@CR10]; Kasuya et al. [@CR23]). However, currently, viruses are not deemed as a useful means to stop or inhibit cancer since there is no effective way to control the virulence and retaining their replication capability in cancer cells (Kelly and Russell [@CR24]). We have developed a cell-based model in pancreatic cancer at early stages (Chen et al. [@CR6]), which is subsequently extended to therapy model in (Chen et al. [@CR7]). However, compared to classical treatments for pancreatic cancer like surgery, radiotherapy, chemotherapy, virotherapy has its own limitations, which needs further scientific assessment. In particular, the limitations include antiviral immune responses, inefficient delivery of virus as well as the poor virus spread in tumor area (Wennier et al. [@CR45]). Therefore, more research in terms of oncolytic virotherapy is needed.

In the present study, we develop a 3D cellular automata model for oncolytic virotherapy. As we expected, the model is able to simulate cancer progression at early stages, which include the biological processes such as mutation, proliferation and death. Within 1400 h (appropriate 58 days), cancerous cells mutate from healthy somatic cells and then colonize the computational domain as big as $\documentclass[12pt]{minimal}
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                \begin{document}$$15 \times 15 \times 15 \ \mathrm {mm}^3$$\end{document}$. Certainly, the model is scalable and the speed of cancer progression can be adjusted by variation of input parameters. Therefore, different growth trends have been compared and one numerical result of our model could fit experimental results very well. Subsequently, oncolytic virotherapy is phenomenologically simulated in the same domain that is completely occupied by cancer cells. The migration and proliferation of the virus is modeled by using a reaction-diffusion equation, which is solved by a FDM method. Since viruses specifically infect and damage cancer cells, the model predicts cancer attenuation as time evolves. Eventually, normal somatic cells fill in the gap through migration and proliferation.

In addition, Monte Carlo simulations are performed in a 2D model to quantitatively investigate the correlations between several input variables and numerical results. Among 5000 samples, there are 700 simulations ending with few residual viruses and large cancer area, which dues to failed virotherapy probably as results of the extreme parameter values. The results indicate an insignificant correlation between the injection dose of viruses and simulated results (total residual viruses and cancer area), and that is probably because of an improper value range of injection rate, an insufficient simulation time period or a limited computational domain. However, we believe that this result is acceptable, since some virus species, such as NDV, show a high correlation between given doses and therapeutic benefits, whereas others do not (Aghi and Martuza [@CR1]). Further, the viral infection threshold has a significant correlation with total amount of remaining viruses and with the final cancer area, which means that viruses with low viral infectivity likely allow a large cancer area with just few viruses left. Moreover, the anti-viral immune response presents an obvious correlation with the numerical results. Specifically, most simulations end up with relatively fewer viruses if the anti-viral reaction is strong and thereby the corresponding residual cancer area is also larger.

Due to gene mutation (i.e., RAS, TP53), the anti-viral infection ability of cancer cells is weakened, which gives the oncolytic viruses a chance (Chiocca [@CR8]) to infect the cancer cells. Research in oncolytic viruses is not limited to cancer therapy research, also in studies that combine other treatments, such as immunotherapy (Bommareddy et al. [@CR3]) and chemotherapy (Molnar-Kimber et al. [@CR33]). In order to optimize the viral therapy in terms of fighting cancer, and leaving as few viral particles post-therapy as possible, further experimental studies are necessary. The required quantification in order to optimize viral therapy implies that mathematical modeling is a necessary and very helpful step.
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